TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/11/25 16:15 | 3/7/25 | ULS | Ul Solutions Inc. | DE | Health | Biolab | Testing Laboratories | Uggetti Alberto | IL | O | EVP,CCO | 1 | S | -103 | 53.00 | 0 | -2 | 9 | D | |||||||||||||||
2/25/25 16:41 | 2/23/25 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | Olivo Alicia C | FL | O | EVP,GC,B | 1 | M.d | 0 | 0.00 | 0 | 8 | 23 | 45 | D | ||||||||||||||
2/25/25 16:40 | 2/23/25 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | Harris Melody | FL | O | Chf Ops | 1 | M.d | 0 | 0.00 | 0 | 8 | 8 | 110 | D | ||||||||||||||
2/25/25 16:39 | 2/23/25 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | Stone Warren | FL | O | Chief Co | 1 | M.d | 0 | 0.00 | 0 | 8 | 10 | 91 | D | ||||||||||||||
2/25/25 16:38 | 2/23/25 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | Sherman Jeffrey Scott | FL | O | CFO | 1 | M.d | 0 | 0.00 | 0 | 16 | 13 | 137 | D | ||||||||||||||
2/25/25 16:37 | 2/23/25 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | Smith Christopher M | FL | O | CEO | 1 | M.d | 0 | 0.00 | 0 | 57 | 10 | 642 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |